| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105 [C. J., S. S. M., J. N.], and Department of Biochemistry, University of Medicine and Dentistry-New Jersey Medical School, Newark, New Jersey 07103 [H. I., M. J. L., C. S. Y.]
The metabolism was examined of the esophageal carcinogen N-nitrosomethylamylamine (NMAA) by liver microsomes and slices from adult male Sprague-Dawley rats. Hydroxylation at C-2 to C-5 of the amyl group to give stable hydroxy-NMAAs was studied by gas chromatography-thermal energy analysis to determine the products. Microsomal metabolism produced mainly 4-hydroxy-NMAA, proceeded optimally in 100 mM phosphate at pH 7.4, and showed no sex differences. Induction by phenobarbital (PB) and 3-methylcholanthrene produced effects which were similar in slices and microsomes, with PB inducing hydroxylation at all positions and 3-methylcholanthrene specifically inducing 3-hydroxylation by factors of 2- and 6-fold. Clofibrate and isoniazid treatments did not affect NMAA metabolism by liver slices. Aroclor-1254 strongly induced microsomal 2- and 3-hydroxylation. For 2- to 5-hydroxylation, Km values for uninduced microsomes were, respectively, 1.6, 1.2, 0.3, and 1.1 mM, with Vmax of 0.08, 0.26, 1.06, and 0.15 nmol/min/mg protein. With PB-induced microsomes, all 4 Km values were 0.40.7 mM.
Liver microsomal production of nitrite and aldehydes from NMAA was determined colormetrically or (for pentaldehyde) by high-pressure liquid chromatography of the 2,4-dinitrophenylhydrazone. Uninduced microsomes produced nitrite, formaldehyde and pentaldehyde from 0.6 mM NMAA at rates that were, respectively, 0.15, 0.72, and 1.15 times that for 4-hydroxylation. PB especially induced depentylation, whereas 3-methylcholanthrene induced depentylation and denitrosation, but suppressed demethylation. A reconstituted system containing cytochrome P-450 IIB1 gave metabolite ratios similar to those in PB-induced microsomes. The results account for most of the possible primary metabolites of NMAA and demonstrate the selectivity for metabolism at each position.
1 This work was supported by NIH Grants RO1-CA-35628 and RO1-CA-37037, Core Grant CA-36727 from the National Cancer Institute, and Core Grant ACS-SIG-16 from the American Cancer Society. Some of these results were presented at the 79th Annual Meeting of the. American Association for Cancer Research, May 2528, 1988 (1).
2 Visiting scientist from the Cancer Institute, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
3 To whom requests for reprints should be addressed.
4 Present address: Department of Chemical Biology and Pharmacognosy, College of Pharmacy, Rutgers University, Piscataway, NH 08855.
Received 3/16/89. Revised 6/19/89. Accepted 7/ 6/89.
This article has been cited by other articles:
![]() |
S. C. Chen, L. Zhou, X. Ding, and S. S. Mirvish Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3 Drug Metab. Dispos., September 1, 2001; 29(9): 1221 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Teiber, K. Mace, and P. F. Hollenberg Metabolism of the {beta}-oxidized intermediates of N-nitrosodi-n-propylamine: N-nitroso-{beta}-hydroxypropylpropylamine and N-nitroso-{beta}-oxopropylpropylamine Carcinogenesis, March 1, 2001; 22(3): 499 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Teiber and P. F. Hollenberg Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine Carcinogenesis, August 1, 2000; 21(8): 1559 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Chen, X. Wang, G. Xu, L. Zhou, J. L. Vennerstrom, F. Gonzalez, H. V. Gelboin, and S. S. Mirvish Depentylation of [3H-pentyl]Methyl-n-amylnitrosamine by Rat Esophageal and Liver Microsomes and by Rat and Human Cytochrome P450 Isoforms Cancer Res., January 1, 1999; 59(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |